Comorbidity-Adjusted Survival in Early Stage Lung Cancer Patients Treated with Hypofractionated Proton Therapy

Objective. To determine the influence of comorbidity on survival in early-stage lung cancer patients treated with proton radiotherapy, using the Charlson Comorbidity Index. Study Design and Setting. Fifty-four non-small-cell lung cancer patients, treated prospectively in a phase II clinical trial wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Do, Sharon Y., Bush, David A., Slater, Jerry D.
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2010
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2995909/
https://www.ncbi.nlm.nih.gov/pubmed/21151644
http://dx.doi.org/10.1155/2010/251208

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2995909/
https://www.ncbi.nlm.nih.gov/pubmed/21151644
http://dx.doi.org/10.1155/2010/251208

Ejemplares similares